Identification of serum tumor markers for malignant disease using high-throughput proteomic technologies
碩士 === 長庚大學 === 醫學生物技術研究所 === 92 === Background: Malignant tumors are at the top leading cause of death in Taiwan in the past decades. Currently, there is no serum marker for detecting oral or nasopharyngeal cancers (ORC or NPC), neither available serum marker with high sensitivity and specificity f...
Main Authors: | Li-chiu Chen, 陳麗秋 |
---|---|
Other Authors: | Ann-joy Cheng |
Format: | Others |
Language: | zh-TW |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/73930771765341250337 |
Similar Items
-
Identification of Potential Prognostic Markers for Knee Osteoarthritis by Serum Proteomic Analysis
by: Yoshihiko Takinami, et al.
Published: (2013-07-01) -
Identification of Potential Prognostic Markers for Knee Osteoarthritis by Serum Proteomic Analysis
by: Yoshihiko Takinami, et al.
Published: (2013-01-01) -
Systemic sclerosis complicated with malignant pleural effusion with high serum CA-125 tumor marker
by: Sourindra Nath Banerjee, et al.
Published: (2015-01-01) -
High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
by: Thilde Terkelsen, et al.
Published: (2021-02-01) -
High Throughput Identification of Antihypertensive Peptides from Fish Proteome Datasets
by: Yunhai Yi, et al.
Published: (2018-10-01)